Your weekly roundup of the latest news from Drug Topics®.
The pharmaceutical giant announced a 70% price reduction for most of its commonly sold insulin.
VP-102 hopes to treat molluscum contagiosum, pending approval from FDA
CMS has no plans to change their coverage and approval process, which the Alzheimer's Association believes is standing between patients and treatment.
The PDFUA date for the drug is October 13, 2023.
Podcast: Discussing the Shared Central Fulfillment Solution with iA
May 6th 2024Brian Nowosielski, associate editor with Drug Topics, sat down with Tom Utech and Reed Richardson of iA, an innovative pharmacy fulfillment company. Utech, CEO of iA, and Richardson, Chief Commercial Officer of iA, discussed the company's new shared central fulfillment solution. The new solution, designed to streamline processes within the pharmacy, is a technological innovation with life-saving benefits for patients.